Payroll Tax Analyst
PTC Therapeutics
Payroll Tax Analyst
PTC Therapeutics
Biopharmaceuticals for rare genetic disorders
PTC Therapeutics is a global commercial biopharmaceutical company. For over 25 years our team has been deeply committed to a unified purpose: Extending life’s moments for children and adults living with a rare disease.
At PTC, we cultivate an inclusive culture where everyone feels valued, respected, and empowered. We welcome candidates from all backgrounds to join our team, fostering a strong sense of belonging.
Visit our website to learn more about our company and culture!
Site: www.ptcbio.com
Responsibilities:
Qualifications:
Special knowledge or skills and/or licenses or certificates preferred.
Travel requirements: 5-10%
Expected Base Salary Range: $80,500 - $90,000. The base salary offered will be contingent on assessment of candidate education level, background, and experience relative to the requirements of the position they are being considered for, as well as review of internal equity.
In addition to base salary, PTC employees are also eligible for short- and long-term incentives. All eligible employees may also enroll in PTC’s medical, dental, vision, and retirement savings plans
EEO Statement:
PTC Therapeutics is an equal opportunity employer. We welcome applications from all individuals, regardless of race, color, national origin, gender, age, physical characteristics, social origin, disability, religion, family status, pregnancy, sexual orientation, gender identity, gender expression, disability, veteran status or any unlawful criterion under applicable law. We are committed to treating all applicants fairly and avoiding discrimination.
Biopharmaceuticals for rare genetic disorders
PTC Therapeutics develops and commercializes treatments for rare genetic disorders worldwide, leveraging RNA biology and post-transcriptional control. Its portfolio includes Translarna (ataluren) for nonsense-mutant Duchenne muscular dystrophy, Evrysdi (risdiplam) for spinal muscular atrophy, Emflaza (deflazacort) for DMD, and Upstaza for AADC deficiency, among others. The company uses an integrated model spanning discovery, clinical development, manufacturing, and global commercialization, with operations in 50+ countries and a European base in Dublin. Its goal is to provide safe, effective therapies for patients with limited treatment options and to grow a robust pipeline in rare diseases.
Explore more opportunities at PTC Therapeutics